Continuity of GxP – for the benefit of nations’ health
On 22 April 2021 in Moscow there will be an opening ceremony of the Eurasian Academy of Good Practices: an educational institution, which is responsible for facilitating qualification enhancement of pharmaceutical inspectors from different countries of the world, implementing good practices in the pharmaceutical industry, and also joining of pharmaceutical inspectorates of the Eurasian Economic Union (EEU) member-states the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and developing export opportunities of the Union’s companies.
Opening of the Eurasian Academy of Good Practices will mark a new milestone in the history of the development of the pharmaceutical quality system of the Eurasian zone: such educational institutions are present in many countries with the developed regulatory system in the pharmaceutical industry that it is the cornerstone of the conformity of drugs to global quality standards. The continuity of knowledge and experience, on the one hand, and keeping up to date with global trends and approaches in drugs manufacturing, on the other, shape those high standards of manufacturing and inspections that are increasingly becoming the pillars for forming the drug safety of the country.
“From the very beginning of the establishment of the Russian GMP Inspectorate we place great emphasis on issues related to training and qualification enhancement of our inspectors, since it is professional competencies that play a crucial role in preserving and protecting patients”. And today, when the Russian GMP Inspectorate is celebrating its fifth anniversary, we can proudly say that these important values lay its foundation. Opening of the Eurasian Academy of Good Practices will be yet another serious step towards the development of a unified field for cooperation in the field of GxP for the pharmaceutical inspectorates of the Union’s states as well as for representatives of the pharmaceutical industry”, – noted Deputy Head of the Russian GMP Inspectorate, Director of FSI “SID&GP” Vladislav Shestakov.
The program of the grand opening of the Eurasian Academy of Good Practices includes the signing of the first cooperation agreement between the Academy and the Eurasian Economic Commission, an official press briefing, as well as the first meeting of the Board of Trustees of the Eurasian Academy of Good Practices, in terms of which the key objectives of the new educational platform will be discussed.
In addition, as part of the opening there will be a meeting of the Eurasian Economic Commission working group, during which it is planned to discuss the current situation on the creation of the EAEU single market of medicines circulation and the harmonization of national legislations of the EAEU member states with the supranational legislation of the Union regarding the GMP inspections of pharmaceutical manufacturing facilities.
The opening ceremony of the Academy will be attended by top officials of relevant ministries and agencies of the Eurasian Economic Union member states, the Eurasian Economic Commission, representatives of regulatory bodies of the Union states, industry communities and associations, as well as heads of pharmaceutical companies.
To register for the event as a speaker or participant, as well as to gain access to the online broadcast of the opening ceremony of the Eurasian Academy of Good Practices, please fill out the form on the website www.gxp-academy.org.
If you have questions, regarding participation and media accreditation, please contact: Elizaveta Ivanenko, e-mail: ivanenko.ei@gilsinp.ru or Anna Belova, e-mail: a.belova@pharmprobeg.ru.
Background. FSI “State Institute of Drugs and Good Practices” (FSI “SID&GP”) is a subordinate authority of the Ministry of Industry and Trade of the Russian Federation, authorized since 2015 to inspect for compliance with GMP rules manufacturers of medical products for human use, whose manufacturing sites are outside the Russian Federation, in order to issue GMP Certificates for the manufacturer of medical products. The Eurasian Academy of Good Practices is a subsidiary of the FSI “SID&GP”.
Other materials
- FSI “SID & GP” and CDSCO, India signed a cooperation agreement.
- The importance of reference samples in the development of pharmaceutical industry was discussed during the meeting of the Healthcare Commission of the General Council of the UNITED RUSSIA Party
- The program of the IX All-Russian GMP Conference with international participation has been published
- Attendees of the ‘Ensuring Drug Security’ Forum discussed issues of public trust in the Russian pharmaceutical products
- Vladislav Shestakov took part in the 8th International Pharmaceutical Congress Russia – Nicaragua “Evolution of Production Potential: Localization of Production to Strengthen the International Health Care System”